Kraig Biocraft Laboratories Unveils Groundbreaking Scientific Achievement Based on Caddisfly Silk Proteins

Associated Press

10-02-2025

ANN ARBOR, Mich., Feb. 10, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ('the Company' or 'Kraig Labs'), a leading developer of spider silk-based fibers, proudly announces the successful creation of new novel silk, build upon the silk proteins of the remarkable caddisfly. This breakthrough marks a new frontier in the field of engineered fibers and underscores the Company's commitment to pioneering innovations in biotechnology.
Caddisflies (known in the Pacific Northwest as 'Periwinkles') are known for their extraordinary ability to spin silk underwater, which they use to construct protective cases in aquatic environments. By leveraging the unique mechanical and chemical attributes of caddisfly silk proteins, Kraig Labs seeks to engineer materials with unprecedented functionality. This new silk offers the potential for increased durability when submerged in water. Possible applications for this new silk are vast, with exciting potentials for medical adhesives, biomedical textiles, performance apparel, and next-generation fiber technologies.
'This achievement demonstrates our ability to extend beyond spider silk proteins and explore the broader possibilities of silk engineering,' said CEO and Founder of Kraig Labs, Kim Thompson. 'By tapping into the evolutionary diversity of silk-producing organisms, we're expanding the toolkit for creating super fibers that meet the demands of tomorrow's industries.'
The introduction of caddisfly-based transgenic fiber represents a critical milestone in the Company's vision to create new super materials blending the physical and chemical properties of various silk proteins. The result is an ever-growing portfolio of high-performance materials designed to redefine the standards of strength, elasticity, and functionality. These new fibers will leverage the Company's propriety silkworm-based production system to bring these materials to market.
'Incorporating the unique and incredible adhesive properties of caddisfly silk protein has been a key part of the R&D roadmap I laid out when founding Kraig Labs,' Thompson continued. 'Unveiling this pivotal scientific milestone, our first caddisfly-based transgenic, marks not only a significant leap forward for the Company's business model but also a deeply gratifying achievement for me personally and for our team.'
This breakthrough would not have been possible without the dedication and ingenuity of the Company's scientific team. Their relentless pursuit of excellence and creative problem-solving have once again positioned Kraig Labs at the forefront of biotechnological innovation.
'Our team's success with this caddisfly-inspired material is a testament to the power of combining cutting-edge science with bold vision,' added the Company's COO, Jon Rice. 'We are excited about the potential this fiber holds and the new opportunities it creates across multiple sectors.'
Kraig Labs is committed to pushing the boundaries of creativity and science in silk protein engineering. The Company has filed a provisional utility patent application for this exciting new technology. By exploring and integrating the diverse properties of silk from various species, the Company will continue to lead the charge in developing sustainable, high-performance materials that address real-world challenges.
For details about other recent advancements that Kraig Labs has made, please watch the Company's investor conference at www.kraiglabs.com/videos or on the Company's YouTube Channel https://www.youtube.com/@kraigbiocraftlaboratories2270.
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. ( www.KraigLabs.com), a reporting biotechnology company is the leading developer of genetically engineered spider silk-based fiber technologies.
The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company's future and expectations other than historical facts are 'forward-looking statements.' These statements are made on the basis of management's current views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as 'believes,' 'plans,' 'expects,' 'anticipates,' 'foresees,' 'estimated,' 'hopes,' 'if,' 'develops,' 'researching,' 'research,' 'pilot,' 'potential,' 'could' or other words or phrases of similar import. Forward looking statements include descriptions of the Company's business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC